Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
53Biologics logo — Decoding Biologics Production

53Biologics

Decoding Biologics Production

Founded 2017 Spain Spain 29 employees Venture round Total: $7.00M Biotechnology, Manufacturing

General Information

Company Name 53Biologics
Founded Year 2017
Location Spain Spain
Employees 29
Industries Biotechnology, Manufacturing
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with 53Biologics. To contact 53Biologics, visit 53biologics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 53Biologics compare?

A PDF of 53Biologics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 53Biologics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 53Biologics

53Biologics is a Spanish contract development and manufacturing organization (CDMO) specializing in decoding biologics production, ranging from pDNA, mRNA to recombinant proteins. The company offers a range of services from preclinical and clinical development to GMP manufacturing, with a focus on supporting biopharma clients in bringing their biological products to market expeditiously. Notably, 53Biologics ensures high-quality standards and customer-centric services, including cell line development, cell banking, preclinical and clinical development, and contract manufacturing under various conditions - GMP, GMP Like, and non-GMP. Established in 2017, the company operates within the Biotechnology and Manufacturing industries from its headquarters in Spain. The latest development for 53Biologics was a noteworthy €7.00M Venture Round investment from Inveready and GAEA Inversión, finalized on 10 September 2021. For those interested, further information can be obtained by contacting the company directly.

Business keywords: Biologics Production, CDMO, Cell Line Development, GMP Manufacturing, Preclinical Development, Clinical Development, BioPharmaceuticals, pDNA, mRNA, Recombinant Proteins

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €7.00M 2
Inveready GAEA Inversión
Inveready, GAEA Inversión
10 Sep 2021

53Biologics Alternatives & Competitors

View All Alternatives
53Biologics vs
JOINN Biologics US Inc.
JOINN Biologics US Inc. United States

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...

Series B
73 employees
Biopharma, Biotechnology
Compare 53Biologics vs JOINN Biologics US Inc.
53Biologics vs
CMAB Biopharma
CMAB Biopharma China

Exclusively focused on delivering fully integrated CDMO services for biologics

Series B
38 employees
Biopharma, Biotechnology
Compare 53Biologics vs CMAB Biopharma
53Biologics vs
Canton Biologics
Canton Biologics China

Reliable, efficient, and innovative, global biologics CDMSO for Biotech.

Series C
31 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About 53Biologics

Decoding Biologics Production
53Biologics was founded in 2017.
53Biologics is headquartered in Spain.
53Biologics operates in Biotechnology and Manufacturing. Its work centres on Biologics Production, CDMO, Cell Line Development and GMP Manufacturing.
53Biologics has approximately 29 employees.
53Biologics has completed 1 funding round, raising a total of $7.00M. The latest funding stage is Venture round.
Top alternatives and competitors to 53Biologics include JOINN Biologics US Inc., CMAB Biopharma, Canton Biologics, MabPlex International Co., Ltd., Porton Advanced | ATMP CDMO/CRO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
53Biologics and JOINN Biologics US Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 53Biologics, https://bouncewatch.com/company/53biologics, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes